| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 767 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| GECC INTRNTS 5.25 | 2018-09 | PURCHASE | 2020-09 | 2,143 | 2,067 | 76 | ||||
| ISHS CORE S&P 500 | 2018-09 | PURCHASE | 2020-09 | 2,361 | 2,088 | 273 | ||||
| ISHS CORE S&P MDCP | 2018-09 | PURCHASE | 2020-09 | 1,850 | 2,073 | -223 | ||||
| ISHS NASDAQ BIOTECH | 2017-12 | PURCHASE | 2020-09 | 8,074 | 6,782 | 1,292 | ||||
| VNGRD RUS2000 VL | 2018-09 | PURCHASE | 2020-09 | 1,510 | 2,030 | -520 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| LPL BROKERAGE ACCT | 178,190 | 199,543 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK FEES | 5 | |||
| IN FILING FEE | 32 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL INCOME TAXES | 220 | |||
| FOREIGN TAX PAID | 30 | 30 | 30 |